Adverse events80

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 80

Type	Event	Organ system	Group	Affected	At risk	Events
other	Diastolic hypertension	Vascular disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Pyrexia	General disorders	Onasemnogene Abeparvovec-xioi	12	22	26
other	Use of accessory respiratory muscles	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	5	22	7
other	Contusion	Injury, poisoning and procedural complications	Onasemnogene Abeparvovec-xioi	4	22	4
other	Arthropod bite	Injury, poisoning and procedural complications	Onasemnogene Abeparvovec-xioi	3	22	7
other	Aspartate aminotransferase increased	Investigations	Onasemnogene Abeparvovec-xioi	6	22	9
other	Alanine aminotransferase increased	Investigations	Onasemnogene Abeparvovec-xioi	5	22	8
other	Blood creatine phosphokinase MB increased	Investigations	Onasemnogene Abeparvovec-xioi	2	22	2
other	Gamma-glutamyltransferase increased	Investigations	Onasemnogene Abeparvovec-xioi	2	22	2
other	Lymphocyte count decreased	Investigations	Onasemnogene Abeparvovec-xioi	2	22	2
other	Weight decreased	Investigations	Onasemnogene Abeparvovec-xioi	2	22	2
other	Pericardial effusion	Cardiac disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Pectus excavatum	Congenital, familial and genetic disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Asphyxiating thoracic dystrophy	Congenital, familial and genetic disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Cryptorchism	Congenital, familial and genetic disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	High arched palate	Congenital, familial and genetic disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Thrombocytopenia	Blood and lymphatic system disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Cough	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	7	22	10
other	Respiratory distress	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	6	22	10
other	Respiration abnormal	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	5	22	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03306277/events

API reference For AI assistants

Adverse events80

Sources 3

Read this list from software.